EndoChoice (GI) Tops Q4 EPS by 5c

EndoChoice (NYSE: GI) reported Q4 EPS of ($0.53), $0.05 better than the analyst estimate of ($0.58). Revenue for the quarter came in at $18.5 million versus the consensus estimate of $19.05 million.

GUIDANCE:

EndoChoice sees FY2016 EPS of ($2.01)-($1.95), versus the consensus of ($2.00). EndoChoice sees FY2016 revenue of $86-93 million, versus the consensus of $90.1 million.

For earnings history and earnings-related data on EndoChoice (GI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15